BNP PARIBAS FINANCIAL MARKETS - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 27 filers reported holding SYNTHETIC BIOLOGICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$010.0%0.00%
Q3 2021$0
-100.0%
10.0%0.00%
Q2 2021$1,0000.0%10.0%0.00%
Q1 2021$1,00010.0%0.00%
Q4 2020$010.0%0.00%
Q3 2020$0
-100.0%
10.0%0.00%
Q2 2020$1,00010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.0%0.00%
Q3 2019$0
-100.0%
10.0%0.00%
Q2 2019$1,0000.0%10.0%0.00%
Q1 2019$1,0000.0%10.0%0.00%
Q4 2018$1,000
-66.7%
10.0%0.00%
Q3 2018$3,00010.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 684,926$465,0000.22%
Alyeska Investment Group, L.P. 5,000,000$3,395,0000.04%
Third Security, LLC 378,239$256,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 60,000$41,0000.00%
SCOPUS ASSET MANAGEMENT, L.P. 225,000$153,0000.00%
Virtu Financial LLC 94,070$64,0000.00%
683 Capital Management, LLC 42,858$29,0000.00%
FNY Investment Advisers, LLC 7,000$4,0000.00%
UBS Group AG 3,978$2,0000.00%
BNP PARIBAS FINANCIAL MARKETS 1$1,0000.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders